Variations in DNA subtype and antifungal susceptibility among clinical isolates of Candida tropicalis.

[1]  M. Pfaller.  Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[2]  A. Bolmström,et al.  Quality control guidelines for National Committee for Clinical Laboratory Standards--recommended broth macrodilution testing of ketoconazole and itraconazole , 1996, Journal of clinical microbiology.

[3]  J. Rex,et al.  Quality control guidelines for National Committee for Clinical Laboratory Standards recommended broth macrodilution testing of amphotericin B, fluconazole, and flucytosine , 1995, Journal of clinical microbiology.

[4]  J. Rex,et al.  Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. NIAID Mycoses Study Group and the Candidemia Study Group , 1995, Antimicrobial agents and chemotherapy.

[5]  J. Wingard,et al.  Importance of Candida species other than C. albicans as pathogens in oncology patients. , 1995, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[6]  B. Doebbeling,et al.  Candida tropicalis vertebral osteomyelitis: a late sequela of fungemia. , 1994, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[7]  M. Pfaller,et al.  Antifungal activity of a new triazole, D0870, compared with four other antifungal agents tested against clinical isolates of Candida and Torulopsis glabrata. , 1994, Diagnostic microbiology and infectious disease.

[8]  B. Doebbeling,et al.  Comparison of pulsed-field gel electrophoresis with isoenzyme profiles as a typing system for Candida tropicalis. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  B. Doebbeling,et al.  Restriction fragment analysis of a Candida tropicalis outbreak of sternal wound infections , 1991, Journal of clinical microbiology.

[10]  J. Sobel,et al.  Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. , 1989, Reviews of infectious diseases.

[11]  D. Soll,et al.  Multiple Candida strains in the course of a single systemic infection , 1988, Journal of clinical microbiology.

[12]  B. Wong,et al.  Fungemia in a cancer hospital: changing frequency, earlier onset, and results of therapy. , 1985, Reviews of infectious diseases.

[13]  J. Wingard,et al.  The value of fungal surveillance cultures as predictors of systemic fungal infections. , 1980, The Journal of infectious diseases.

[14]  J. Wingard,et al.  Candida tropicalis: a major pathogen in immunocompromised patients. , 1979, Annals of internal medicine.

[15]  Ellen Jo Baron,et al.  Manual of clinical microbiology , 1975 .